Open AccessImmunogenicity of Rituximab, Trastuzumab, and Bevacizumab Monoclonal Antibodies in Patients with Malignant Diseases
Author(s) -
Fatemeh Saffari,
Abdollah Jafarzadeh,
Behjat Kalantari Khandani,
Farzaneh Saffari,
Saeed Soleimanyamoli,
Mohammad Mahdi Mohammadi
Publication year - 2018
Publication title -
international journal of cancer management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.251
H-Index - 19
eISSN - 2538-4422
pISSN - 2538-497X
DOI - 10.5812/ijcm.64983
Subject(s) - medicine , rituximab , trastuzumab , monoclonal antibody , antibody , bevacizumab , immunogenicity , lymphoma , malignancy , cancer , immunology , oncology , chemotherapy , breast cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom